Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 18, Issue 6, Pages 840-848
Publisher
Oxford University Press (OUP)
Online
2015-12-18
DOI
10.1093/neuonc/nov299
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of low dose temozolomide in combination with bortezomib in U87 glioma cells: a flow cytometric analysis
- (2015) Panagiotis J. Vlachostergios et al. Archives of Medical Science
- Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models
- (2014) Kaijun Di et al. JOURNAL OF NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Differential Effects of the Proteasome Inhibitor NPI-0052 against Glioma Cells
- (2014) Erina Vlashi et al. Translational Oncology
- TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth
- (2012) K Di et al. ONCOGENE
- Specific and prolonged proteasome inhibition dictates apoptosis induction by marizomib and its analogs
- (2011) Claudia P. Miller et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Bortezomib stabilizes NOXA and triggers ROS-associated apoptosis in medulloblastoma
- (2011) Sachiko Ohshima-Hosoyama et al. JOURNAL OF NEURO-ONCOLOGY
- Novel Proteasome Inhibitors to Overcome Bortezomib Resistance
- (2011) Amy M. Ruschak et al. JNCI-Journal of the National Cancer Institute
- Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy
- (2011) X. Gong et al. NEUROLOGY
- Proteasome inhibitors in cancer therapy
- (2011) Lisa J. Crawford et al. Journal of Cell Communication and Signaling
- Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine model
- (2010) Ajita V. Singh et al. BRITISH JOURNAL OF HAEMATOLOGY
- In Vivo Imaging, Tracking, and Targeting of Cancer Stem Cells
- (2009) Erina Vlashi et al. JNCI-Journal of the National Cancer Institute
- Proteasome Inhibition Activates Epidermal Growth Factor Receptor (EGFR) and EGFR-Independent Mitogenic Kinase Signaling Pathways in Pancreatic Cancer Cells
- (2008) C. M. Sloss et al. CLINICAL CANCER RESEARCH
- Mechanisms of proteasome inhibitor action and resistance in cancer
- (2008) David J. McConkey et al. DRUG RESISTANCE UPDATES
- Hypoxia and HIF1α Repress the Differentiative Effects of BMPs in High-Grade Glioma
- (2008) Francesca Pistollato et al. STEM CELLS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started